Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma.

Lao Y, Wu H, Zhao C, Wu Q, Qiao F, Fan H.

Biomed Rep. 2013 Sep;1(5):771-775. Epub 2013 Jul 19.

PMID:
24649027
[PubMed]
Free PMC Article
2.

[Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].

Bao Q, He BS, Chen LP, Gu L, Nie ZL, Wang SK.

Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jan;46(1):53-7. Chinese.

PMID:
22490141
[PubMed - indexed for MEDLINE]
3.

Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.

Ezzikouri S, El Feydi AE, Benazzouz M, Afifi R, El Kihal L, Hassar M, Akil A, Pineau P, Benjelloun S.

Infect Genet Evol. 2009 Sep;9(5):877-81. doi: 10.1016/j.meegid.2009.05.012. Epub 2009 May 22.

PMID:
19465161
[PubMed - indexed for MEDLINE]
4.

Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study.

Fan H, Zhang F, Hu J, Liu D, Zhao Z.

J Exp Clin Cancer Res. 2008 Jul 28;27:24. doi: 10.1186/1756-9966-27-24.

PMID:
18662374
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer.

Bao Q, He B, Pan Y, Tang Z, Zhang Y, Qu L, Xu Y, Zhu C, Tian F, Wang S.

Int J Colorectal Dis. 2011 Sep;26(9):1107-12. doi: 10.1007/s00384-011-1199-3. Epub 2011 Apr 26.

PMID:
21519807
[PubMed - indexed for MEDLINE]
7.

Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study.

Chang KP, Hao SP, Tsang NM, Chang YL, Cheng MH, Liu CT, Lee YS, Tsai CL, Lee TJ, Wang TH, Tsai CN.

Oncol Rep. 2008 Jan;19(1):217-22.

PMID:
18097598
[PubMed - indexed for MEDLINE]
8.

DNMT3B polymorphisms and risk of primary lung cancer.

Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Cho YL, Jung TH, Park JY.

Carcinogenesis. 2005 Feb;26(2):403-9. Epub 2004 Nov 4.

PMID:
15528220
[PubMed - indexed for MEDLINE]
Free Article
9.

DNMT3B promoter polymorphism and risk of gastric cancer.

Hu J, Fan H, Liu D, Zhang S, Zhang F, Xu H.

Dig Dis Sci. 2010 Apr;55(4):1011-6. doi: 10.1007/s10620-009-0831-3. Epub 2009 Jun 11.

PMID:
19517237
[PubMed - indexed for MEDLINE]
10.

Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese population.

Chen Z, Zhou Z, Chen X, Xu J, Liu A, Du W, Gu D, Ge J, Guo Z, Wang X, Dong X, Ren Q, Yang R.

J Clin Immunol. 2008 Sep;28(5):399-404. doi: 10.1007/s10875-008-9198-z. Epub 2008 Apr 25.

PMID:
18437543
[PubMed - indexed for MEDLINE]
11.

DNMT3B 579G>T promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a Chinese population.

Zhao H, Du W, Gu D, Wang D, Xue F, Ge J, Sui T, Yang R.

Acta Haematol. 2009;122(1):31-5. doi: 10.1159/000235616. Epub 2009 Aug 20.

PMID:
19696477
[PubMed - indexed for MEDLINE]
12.

DNMT3B promoter polymorphism and risk of immune thrombocytopenic purpura in pediatric Egyptians.

Shaheen IA, Abukhalil RE, Ali DK, Afifi RA.

Blood Coagul Fibrinolysis. 2012 Oct;23(7):636-9.

PMID:
22885766
[PubMed - indexed for MEDLINE]
13.

Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study.

Liu Z, Wang L, Wang LE, Sturgis EM, Wei Q.

Cancer Lett. 2008 Sep 8;268(1):158-65. doi: 10.1016/j.canlet.2008.03.034. Epub 2008 May 1.

PMID:
18455294
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk.

Singal R, Das PM, Manoharan M, Reis IM, Schlesselman JJ.

Oncol Rep. 2005 Aug;14(2):569-73.

PMID:
16012746
[PubMed - indexed for MEDLINE]
15.

DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome.

Coppedè F, Bosco P, Tannorella P, Romano C, Antonucci I, Stuppia L, Romano C, Migliore L.

Hum Reprod. 2013 Feb;28(2):545-50. doi: 10.1093/humrep/des376. Epub 2012 Oct 18.

PMID:
23081874
[PubMed - indexed for MEDLINE]
Free Article
16.

Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study.

Chang KP, Hao SP, Liu CT, Cheng MH, Chang YL, Lee YS, Wang TH, Tsai CN.

Oral Oncol. 2007 Apr;43(4):345-51. Epub 2006 Aug 22.

PMID:
16920385
[PubMed - indexed for MEDLINE]
17.

DNMT3A -448A>G polymorphism and the risk for hepatocellular carcinoma.

Zhao C, Yan F, Wu H, Qiao F, Qiu X, Fan H.

Biomed Rep. 2013 Jul;1(4):664-668. Epub 2013 May 30.

PMID:
24649006
[PubMed]
Free PMC Article
18.

Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis.

Coppedè F, Ricciardi R, Denaro M, De Rosa A, Provenzano C, Bartoccioni E, Baggiani A, Lucchi M, Mussi A, Migliore L.

PLoS One. 2013 Nov 19;8(11):e80846. doi: 10.1371/journal.pone.0080846. eCollection 2013.

PMID:
24260492
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

DNA methyltransferase 3B (DNMT3B -579G>T) promotor polymorphism and the susceptibility to pediatric immune thrombocytopenic purpura in Egypt.

Khorshied MM, El-Ghamrawy MK.

Gene. 2012 Dec 10;511(1):34-7. doi: 10.1016/j.gene.2012.09.024. Epub 2012 Sep 18.

PMID:
23000068
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk